Chen et al. reported that MYCN, MEIS2, and HAND2 activated IRF2BP2 through SEs and that the AP-1 family was enriched at its binding sites, synergistically promoting ALK expression to maintain high proliferation of NB (Chen X. et al., 2024). The gene discussed is ALK; the disease is neuroblastoma.